Soluble RAGE further stratifies risk of coronary artery and end-stage kidney disease in high-risk individuals with type 1 diabetes and treatment-resistant hypertension

Abstract Background Soluble receptor for advanced glycation end-products (sRAGE) modulates RAGE-mediated inflammation and oxidative stress. We investigated if sRAGE stratifies cardiovascular and kidney disease risk in individuals with type 1 diabetes and baseline treatment-resistant hypertension (TR...

Повний опис

Бібліографічні деталі

Автори:	Krishna Adeshara, Raija Lithovius, Stefan Mutter, Valma Harjutsalo, Markku Lehto, Per-Henrik Groop, Niina Sandholm, the FinnDiane Study Group
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2025-12-01
Серія:	Cardiovascular Diabetology
Предмети:	Soluble RAGE Treatment-resistant hypertension Coronary artery disease Kidney disease Type 1 diabetes
Онлайн доступ:	https://doi.org/10.1186/s12933-025-03017-8
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!